Envestnet Asset Management Inc. Grows Holdings in Quanterix Corporation $QTRX

Envestnet Asset Management Inc. boosted its position in Quanterix Corporation (NASDAQ:QTRX) by 122.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 515,861 shares of the company’s stock after buying an additional 284,260 shares during the quarter. Envestnet Asset Management Inc. owned 1.11% of Quanterix worth $2,801,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. HUB Investment Partners LLC acquired a new position in shares of Quanterix in the second quarter worth about $81,000. Brevan Howard Capital Management LP purchased a new stake in Quanterix during the 2nd quarter worth approximately $96,000. State of Wyoming raised its position in shares of Quanterix by 105.3% in the 2nd quarter. State of Wyoming now owns 14,814 shares of the company’s stock valued at $99,000 after purchasing an additional 7,599 shares in the last quarter. Quantbot Technologies LP boosted its stake in shares of Quanterix by 182.7% during the 2nd quarter. Quantbot Technologies LP now owns 31,864 shares of the company’s stock valued at $212,000 after buying an additional 20,592 shares during the last quarter. Finally, Quantinno Capital Management LP grew its position in shares of Quanterix by 307.4% during the second quarter. Quantinno Capital Management LP now owns 41,964 shares of the company’s stock worth $279,000 after buying an additional 31,664 shares in the last quarter. 86.48% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently issued reports on QTRX shares. Wall Street Zen raised shares of Quanterix from a “sell” rating to a “hold” rating in a report on Monday, December 29th. Weiss Ratings restated a “sell (d-)” rating on shares of Quanterix in a research note on Thursday, January 22nd. Finally, Canaccord Genuity Group increased their price target on shares of Quanterix from $5.00 to $8.00 and gave the stock a “hold” rating in a research report on Monday, December 22nd. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Quanterix presently has a consensus rating of “Hold” and a consensus target price of $11.33.

Quanterix Stock Performance

Quanterix stock opened at $6.29 on Thursday. Quanterix Corporation has a 1 year low of $4.05 and a 1 year high of $8.77. The firm’s 50-day moving average is $6.52 and its 200-day moving average is $5.96. The company has a market cap of $293.81 million, a P/E ratio of -2.70 and a beta of 1.09.

Quanterix Company Profile

Quanterix Corporation is a life sciences and diagnostics company specializing in ultra-sensitive digital immunoassay platforms. Its proprietary Single Molecule Array (Simoa) technology enables researchers to detect and quantify proteins, peptides and nucleic acids at femtomolar concentrations, offering sensitivity that surpasses traditional immunoassay methods. By translating single-molecule detection into routine laboratory workflows, Quanterix aims to accelerate biomarker discovery and the development of novel diagnostics and therapeutics.

The company’s core product portfolio includes the Simoa HD-1 and HD-X Analyzers, which automate high-throughput digital immunoassays for quantifying low-abundance biomarkers.